While substance use and substance use disorders (SUDs) are increasing in prevalence and severity throughout the United States, a minority of people with SUDs are in formal treatment. The ED is a key site of medical care for patients with SUDs and presents an important opportunity for SUD treatment initiation and linkage to care. Even in a brief clinical encounter, emergency clinicians can have a meaningful impact on patients’ lives through SUD screening and identification, provision of harm reduction services, initiation of and linkage to SUD treatment, and linkage to services to address unmet health-related social needs. SUDs have complex biopsychosocial components and a bidirectional relationship with social determinants of health. Therefore, a comprehensive approach to SUDs must include addressing health-related social needs. Partnering with community organizations, specialty societies, and policy makers, EDs and hospitals can work to address social determinants of health which are related to harmful substance use and present barriers to treatment initiation and retention. In this chapter, we describe a social emergency medicine approach to caring for people with SUDs in the ED, highlight model ED and health system initiatives to address SUD and social determinants of substance use, and outline key structural and social determinants of SUDs.
- Substance use
- Harm reduction
- Alcohol use
- Opioid use
- Addiction medicine
This is a preview of subscription content, access via your institution.
Bernstein SL, D'Onofrio G. A promising approach for emergency departments to care for patients with substance use and behavioral disorders. Health Aff (Millwood). 2013;32(12):2122–8.
White AM, Slater ME, Ng G, Hingson R, Breslow R. Trends in alcohol-related emergency department visits in the United States: results from the nationwide emergency department sample, 2006 to 2014. Alcohol Clin Exp Res. 2018;42(2):352–9.
Weiss A, Bailey M, O'Malley L, Barrett M, Elixhauser A, Steiner C. Patient characteristics of opioid-related inpatient stays and emergency department visits nationally and by state, 2014. Agency for Healthcare Research and Quality: Rockville; 2017.
Vivolo-Kantor AM, Seth P, Gladden RM, Mattson CL, Baldwin GT, Kite-Powell A, et al. Vital signs: trends in emergency department visits for suspected opioid overdoses – United States, July 2016–September 2017. MMWR Morb Mortal Wkly Rep. 2018;67(9):279–85.
Han BH, Moore AA, Sherman S, Keyes KM, Palamar JJ. Demographic trends of binge alcohol use and alcohol use disorders among older adults in the United States, 2005–2014. Drug Alcohol Depend. 2017;170:198–207.
Grucza RA, Sher KJ, Kerr WC, Krauss MJ, Lui CK, McDowell YE, et al. Trends in adult alcohol use and binge drinking in the early 21st-century United States: a meta-analysis of 6 national survey series. Alcohol Clin Exp Res. 2018;42(10):1939–50.
Centers for Disease Control and Prevention. Average for United States 2006–2010 alcohol-attributable deaths due to excessive alcohol use 2013. Available from: www.cdc.gov/ARDI.
Centers for Disease Control and Prevention. Multiple cause of death 1999–2017 on CDC WONDER online database: National Center for Health Statistics.; December 2018. Available from: https://wonder.cdc.gov/mcd.html.
NIDA. Overdose Death Rates 2019 [updated January 2019]. Available from: https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates.
Spencer MR, Warner M, Bastian BA, Trinidad JP, Hedegaard H. Drug overdose deaths involving fentanyl, 2011–2016. Hyattsville: National Center for Health Statistics; 2019. Contract No.: 3.
Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths – United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016;65(5051):1445–52.
Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths – United States, 2013–2017. MMWR Morb Mortal Wkly Rep. 2018;67(5152):1419–27.
NIDA. Nationwide trends June 25, 2015. Available from: https://www.drugabuse.gov/publications/drugfacts/nationwide-trends.
Mack KA, Jones CM, Ballesteros MF. Illicit drug use, illicit drug use disorders, and drug overdose deaths in metropolitan and nonmetropolitan areas – United States. MMWR Surveill Summ. 2017;66(19):1–12.
National Survey on Drug Use and Health 2018 [Internet]. 2020. Available from: https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health.
Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2018 National Survey on Drug Use and Health (HHS Publication No. PEP19-5068, NSDUH Series H-54). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration: Rockville; 2019.
Andrilla CHA, Moore TE, Patterson DG, Larson EH. Geographic distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment of opioid use disorder: a 5-year update. J Rural Health. 2019;35(1):108–12.
Haffajee RL, Lin LA, Bohnert ASB, Goldstick JE. Characteristics of us counties with high opioid overdose mortality and low capacity to deliver medications for opioid use disorder. JAMA Netw Open. 2019;2(6):e196373.
Lagisetty PA, Ross R, Bohnert A, Clay M, Maust DT. Buprenorphine treatment divide by race/ethnicity and payment. JAMA Psychiatry. 2019;76(9):979–81.
Kulesza M, Matsuda M, Ramirez JJ, Werntz AJ, Teachman BA, Lindgren KP. Towards greater understanding of addiction stigma: intersectionality with race/ethnicity and gender. Drug Alcohol Depend. 2016;169:85–91.
American Psychiatric Association. Substance-related and addictive disorders. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, D.C.: American Psychiatric Association; 2013.
Shin SH, McDonald SE, Conley D. Patterns of adverse childhood experiences and substance use among young adults: a latent class analysis. Addict Behav. 2018;78:187–92.
Svingen L, Dykstra RE, Simpson JL, Jaffe AE, Bevins RA, Carlo G, et al. Associations between family history of substance use, childhood trauma, and age of first drug use in persons with methamphetamine dependence. J Addict Med. 2016;10(4):269–73.
Hughes K, Bellis MA, Hardcastle KA, Sethi D, Butchart A, Mikton C, et al. The effect of multiple adverse childhood experiences on health: a systematic review and meta-analysis. The Lancet Public Health. 2017;2(8):e356–e66.
Dube SR, Felitti VJ, Dong M, Chapman DP, Giles WH, Anda RF. Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: the adverse childhood experiences study. Pediatrics. 2003;111(3):564–72.
Doran KM, Rahai N, McCormack RP, Milian J, Shelley D, Rotrosen J, et al. Substance use and homelessness among emergency department patients. Drug Alcohol Depend. 2018;188:328–33.
Compton WM, Jones CM, Baldwin GT. Relationship between nonmedical prescription-opioid use and heroin use. N Engl J Med. 2016;374(2):154–63.
Rigg KK, Monnat SM. Urban vs. rural differences in prescription opioid misuse among adults in the United States: informing region specific drug policies and interventions. Int J Drug Policy. 2015;26(5):484–91.
Case A, Deaton A. Mortality and morbidity in the 21st century: Washington, DC. Brookings Institute; 2017.
Ulirsch JC, Weaver MA, Bortsov AV, Soward AC, Swor RA, Peak DA, et al. No man is an island: Living in a disadvantaged neighborhood influences chronic pain development after motor vehicle collision. Pain. 2014;155(10):2116–23.
Knapp EA, Bilal U, Dean LT, Lazo M, Celentano DD. Economic insecurity and deaths of despair in US Counties. Am J Epidemiol. 2019;188(12):2131–9.
Goedel WC, Shapiro A, Cerda M, Tsai JW, Hadland SE, Marshall BDL. Association of racial/ethnic segregation with treatment capacity for opioid use disorder in counties in the United States. JAMA Netw Open. 2020;3(4):e203711.
Saloner B, Cook BL. Blacks and hispanics are less likely than whites to complete addiction treatment, largely due to socioeconomic factors. Health Affairs. 2013;32(1):135–45.
Frieden TR. Shattuck lecture: the future of public health. N Engl J Med. 2015;373(18):1748–54.
Finkelhor D, Turner HA, Shattuck A, Hamby SL. Violence, crime, and abuse exposure in a national sample of children and youth: an update. JAMA Pediatr. 2013;167(7):614–21.
Finkelhor D, Turner HA, Shattuck A, Hamby SL. Prevalence of childhood exposure to violence, crime, and abuse: results from the national survey of children's exposure to violence. JAMA Pediatr. 2015;169(8):746–54.
Smith SG, Zhang X, Basile KC, Merrick MT, Wang J, Kresnow M, et al. The National Intimate Partner and Sexual Violence Survey (NISVS): 2015 data brief – updated release. National Center for Injury Prevention and Control, Centers for Disease Control and Prevention: Atlanta; 2018.
Center for Substance Abuse Treatment. Trauma-informed care in behavioral health services. Rockville: Substance Abuse and Mental Health Services Administration; 2014.
Substance Abuse and Mental Health Services Administration. SAMHSA’s concept of trauma and guidance for a trauma-informed approach. HHS Publication No. (SMA) 14-4884. Substance Abuse and Mental Health Services Administration: Rockville; 2014.
Corbin TJ, Purtle J, Rich LJ, Rich JA, Adams EJ, Yee G, et al. The prevalence of trauma and childhood adversity in an urban, hospital-based violence intervention program. J Health Care Poor Underserved. 2013;24(3):1021–30.
Hawk K, D'Onofrio G. Emergency department screening and interventions for substance use disorders. Addict Sci Clin Pract. 2018;13(1):18.
Bernstein E, Topp D, Shaw E. A preliminary report of knowledge translation: lessons from taking screening and brief intervention techniques from the research setting into regional systems of care. Acad Emerg Med. 2009;16:1225.
SBIRT: Screening, Brief Intervention, and Referral to Treatment Washington, D.C.: SAMHSA-HRSA Center for Integrated Health Solutions. Available from: https://www.integration.samhsa.gov/clinical-practice/sbirt.
Madras BK, Compton WM, Avula D, Stegbauer T, Stein JB, Clark HW. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later. Drug Alcohol Depend. 2009;99(1-3):280–95.
Barata IA, Shandro JR, Montgomery M, Polansky R, Sachs CJ, Duber HC, et al. Effectiveness of SBIRT for alcohol use disorders in the emergency department: a systematic review. West J Emerg Med. 2017;18(6):1143–52.
Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. Primary care validation of a single-question alcohol screening test. J Gen Intern Med. 2009;24(7):783–8.
Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. A single-question screening test for drug use in primary care. Arch Intern Med. 2010;170(13):1155–60.
AUDIT-C Overview. Available from: https://www.integration.samhsa.gov/images/res/tool_auditc.pdf.
O'Brien CP. The CAGE questionnaire for detection of alcoholism: a remarkably useful but simple tool. JAMA. 2008;300(17):2054–6.
NIAAA. Helping patients who drink too much: a clinician’s guide. National Institute on Alcohol Abuse and Alcoholism; Washington, DC. 2005.
Bernstein E, Topp D, Shaw E, Girard C, Pressman K, Woolcock E, et al. A preliminary report of knowledge translation: lessons from taking screening and brief intervention techniques from the research setting into regional systems of care. Acad Emerg Med. 2009;16(11):1225–33.
Smith PC, Cheng DM, Allensworth-Davies D, Winter MR, Saitz R. Use of a single alcohol screening question to identify other drug use. Drug Alcohol Depend. 2014;139:178–80. https://doi.org/10.1016/j.drugalcdep.2014.03.027. Epub 2014 Apr 5. PMID: 24768061; PMCID: PMC4085274.
Committee on Substance A, Levy SJ, Kokotailo PK. Substance use screening, brief intervention, and referral to treatment for pediatricians. Pediatrics. 2011;128(5):e1330–40.
Knight JR, Sherritt L, Shrier LA, Harris SK, Chang G. Validity of the CRAFFT substance abuse screening test among adolescent clinic patients. Arch Pediatr Adoles Med. 2002;156(6):607.
The Center for Adolescent Substance Use Research. The CRAFFT 2.1 manual. Boston: The Center for Adolescent Substance Use Research; 2018.
Miller WR, Rollnick S. Motivational interviewing: preparing people to change addictive behavior. New York: The Guilford Press; 2013.
Counselman FL, Babu K, Edens MA, Gorgas DL, Hobgood C, Marco CA, et al. The 2016 model of the clinical practice of emergency medicine. J Emerg Med. 2017;52(6):846–9.
Lemhoefer C, Rabe GL, Wellmann J, Bernstein SL, Cheung KW, McCarthy WJ, et al. Emergency department-initiated tobacco control: update of a systematic review and meta-analysis of randomized controlled trials. Prev Chronic Dis. 2017;14:E89.
CA BRIDGE. Resources. https://cabridge.org/tools/resources/. Accessed 26 Feb 2021.
Ketcham E, Ryan R. BUPE: buprenorphine use in the Emergency Department Tool Dallas, TX: American College of Emergency Physicians; 2018. Available from: https://www.acep.org/patient-care/bupe/.
D'Onofrio G, O'Connor PG, Pantalon MV, Chawarski MC, Busch SH, Owens PH, et al. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. Jama. 2015;313(16):1636–44.
Mark T, Montejano L, Kranzler H, Chalk M, Gastfriend D. Comparison of healthcare utilization among patients treated with alcoholism medications. Am J Manag Care. 2010;16(12):879–88.
Bernstein SL, D'Onofrio G, Rosner J, O'Malley S, Makuch R, Busch S, et al. Successful tobacco dependence treatment in low-income emergency department patients: a randomized trial. Ann Emerg Med. 2015;66(2):140–7.
Bernstein SL, Boudreaux ED, Cydulka RK, Rhodes KV, Lettman NA, Almeida SL, et al. Tobacco control interventions in the emergency department: a joint statement of emergency medicine organizations. J Emerg Nurs. 2006;32(5):370–81.
Katz DA, Vander Weg MW, Holman J, Nugent A, Baker L, Johnson S, et al. The Emergency Department Action in Smoking Cessation (EDASC) trial: impact on delivery of smoking cessation counseling. Acad Emerg Med. 2012;19(4):409–20.
Duber HC, Barata IA, Cioe-Pena E, Liang SY, Ketcham E, Macias-Konstantopoulos W, et al. Identification, management, and transition of care for patients with opioid use disorder in the emergency department. Ann Emerg Med. 2018;18:S0196–644.
Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550.
Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, et al. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020;3(2):e1920622.
Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2018 National Survey on Drug Use and Health. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration: Rockville; 2019.
Larochelle MR, Bernson D, Land T, Stopka TJ, Wang N, Xuan Z, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a Cohort Study. Ann Intern Med. 2018;169(3):137–45.
Busch SH, Fiellin DA, Chawarski MC, Owens PH, Pantalon MV, Hawk K, et al. Cost-effectiveness of emergency department-initiated treatment for opioid dependence. Addiction. 2017;112(11):2002–10.
Kampman K, Jarvis M. American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use. J Addict Med. 2015;9(5):358–67.
Administering or dispensing of narcotic drugs., 21 CFR § 1306.07(b) (1998).
Davis CS, Carr DH. The law and policy of opioids for pain management, addiction treatment, and overdose reversal. Indiana Health Law Rev. 2017;14(1):1.
D'Onofrio G, McCormack RP, Hawk K. Emergency departments – A 24/7/365 option for combating the opioid crisis. N Engl J Med. 2018;379(26):2487–90.
Substance Abuse and Mental Health Services Administration. Use of medications for opioid use disorder in emergency departments. Rockville: National Mental Health and Substance Use Policy Laboratory; Bethesda, MD, 2019.
CA BRIDGE. Buprenorphine (Bup) Hospital Quick Start. Updated Sept 2020. https://cabridge.org/resource/buprenorphine-bup-hospital-quick-start/. Accessed 26 Feb 2021.
Joudrey PJ, Edelman EJ, Wang EA. Drive times to opioid treatment programs in urban and rural counties in 5 US states. JAMA. 2019;322(13):1310–2.
Grimm C. Geographic disparities affect access to buprenorphine services for opioid use disorder. Washington, D.C.: U.S. Department of Health and Human Services. Office of Inspector General; 2020. Contract No.: OEI-12-17-00240.
Eibl JK, Gauthier G, Pellegrini D, Daiter J, Varenbut M, Hogenbirk JC, et al. The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting. Drug Alcohol Depend. 2017;176:133–8.
Huskamp HA, Busch AB, Souza J, Uscher-Pines L, Rose S, Wilcock A, et al. How is telemedicine being used in opioid and other substance use disorder treatment? Health Aff (Millwood). 2018;37(12):1940–7.
Uscher-Pines L, Huskamp HA, Mehrotra A. Treating patients with opioid use disorder in their homes: an emerging treatment model. JAMA. 2020;324:39.
Yang YT, Weintraub E, Haffajee RL. Telemedicine's role in addressing the opioid epidemic. Mayo Clin Proc. 2018;93(9):1177–80.
Zheng W, Nickasch M, Lander L, Wen S, Xiao M, Marshalek P, et al. Treatment outcome comparison between telepsychiatry and face-to-face buprenorphine medication-assisted treatment for opioid use disorder: a 2-year retrospective data analysis. J Addict Med. 2017;11(2):138–44.
Samuels EA, Clark SA, Wunsch C, Keeler LAJ, Reddy N, Vanjani R, et al. Innovation during COVID-19: improving addiction treatment access. J Addict Med. 2020;14:e8.
Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction. 2010;105(5):844–59.
MacArthur GJ, van Velzen E, Palmateer N, Kimber J, Pharris A, Hope V, et al. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. Int J Drug Policy. 2014;25(1):34–52.
Aspinall EJ, Nambiar D, Goldberg DJ, Hickman M, Weir A, Van Velzen E, et al. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014;43(1):235–48.
Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, et al. Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis. Addiction. 2018;113(3):545–63.
Des Jarlais D, Perlis T, Arasteh K, Torian L, Hagan H, Beatrice S, et al. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990–2001. AIDS. 2005;19(Suppl 3):S20–5.
Nguyen TQ, Weir BW, Des Jarlais DC, Pinkerton SD, Holtgrave DR. Syringe exchange in the United States: a national level economic evaluation of hypothetical increases in investment. AIDS Behav. 2014;18(11):2144–55.
Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174.
Piper TM, Stancliff S, Rudenstine S, Sherman S, Nandi V, Clear A, et al. Evaluation of a naloxone distribution and administration program in New York City. Subst Use Misuse. 2008;43(7):858–70.
Doe-Simkins M, Walley AY, Epstein A, Moyer P. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am J Public Health. 2009;99(5):788–91.
Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis. 2006;25(3):89–96.
Samuels E. Emergency department naloxone distribution: a Rhode Island department of health, recovery community, and emergency department partnership to reduce opioid overdose deaths. R I Med J. 2014;97(10):38–9.
Samuels EA, Baird J, Yang ES, Mello MJ. Adoption and utilization of an emergency department naloxone distribution and peer recovery coach consultation program. Acad Emerg Med. 2019;26(2):160–73.
Samuels EA, Hoppe J, Papp J, Whiteside L, Raja AS, Bernstein E. Naloxone distribution strategies needed in emergency departments. ACEPNow. American College of Emergency Physicians. March 16, 2016. https://www.acepnow.com/article/naloxone-distribution-strategies-needed-in-emergency-departments/.
Dwyer K, Walley AY, Langlois BK, Mitchell PM, Nelson KP, Cromwell J, et al. Opioid education and nasal naloxone rescue kits in the emergency department. West J Emerg Med. 2015;16(3):381–4.
Binswanger IA, Blatchford PJ, Mueller SR, Stern MF. Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann Intern Med. 2013;159(9):592–600.
Bukten A, Stavseth MR, Skurtveit S, Tverdal A, Strang J, Clausen T. High risk of overdose death following release from prison: variations in mortality during a 15-year observation period. Addiction. 2017;112(8):1432–9.
Garg RK, Fulton-Kehoe D, Franklin GM. Patterns of opioid use and risk of opioid overdose death among medicaid patients. Med Care. 2017;55(7):661–8.
Nadpara PA, Joyce AR, Murrelle EL, Carroll NW, Carroll NV, Barnard M, et al. Risk factors for serious prescription opioid-induced respiratory depression or overdose: comparison of commercially insured and veterans health affairs populations. Pain Med. 2018;19(1):79–96.
Naloxone Overdose Prevention Laws: prescription drug abuse policy system; 2017. Available from: http://pdaps.org/datasets/laws-regulating-administration-of-naloxone-1501695139.
Ryan S, Pantalon MV, Camenga D, Martel S, D'Onofrio G. Evaluation of a pediatric resident skills-based screening, brief intervention and referral to treatment (SBIRT) curriculum for substance use. J Adolesc Health. 2018;63(3):327–34.
Duong DK, O'Sullivan PS, Satre DD, Soskin P, Satterfield J. Social workers as workplace-based instructors of alcohol and drug screening, brief intervention, and referral to treatment (SBIRT) for emergency medicine residents. Teach Learn Med. 2016;28(3):303–13.
Tetrault JM, Green ML, Martino S, Thung SF, Degutis LC, Ryan SA, et al. Developing and implementing a multispecialty graduate medical education curriculum on Screening, Brief Intervention, and Referral to Treatment (SBIRT). Subst Abus. 2012;33(2):168–81.
Improving the hospital and emergency department response to substance use disorders: a Project ASSERT Case Study: American Hospital Association; [cited 2019]. Available from: https://www.aha.org/system/files/content/17/project-assert-case-study.pdf.
Project ASSERT: Boston Medical Center. Available from: https://www.bmc.org/programs/project-assert.
The BNI ART Institute. Project ASSERT: SBIRT in Emergency Care: The Boston University School of Public Health. Available from: https://www.bu.edu/bniart/sbirt-experience/sbirt-programs/sbirt-project-assert/.
Faster Paths to Treatment: Boston Medical Center. Available from: https://www.bmc.org/programs/faster-paths-to-treatment.
Welch AE, Jeffers A, Allen B, Paone D, Kunins HV. Relay: a peer-delivered emergency department-based response to nonfatal opioid overdose. Am J Public Health. 2019;109(10):1392–5.
Addiction Policy Forum. Anchor ED. Washington, D.C. February 2017. www.addictionpolicy.org/post/anchored-rhode-island.
Waye KM, Goyer J, Dettor D, Mahoney L, Samuels EA, Yedinak JL, et al. Implementing peer recovery services for overdose prevention in Rhode Island: an examination of two outreach-based approaches. Addict Behav. Washington, D.C. 2019;89:85–91.
McGuire AB, Powell KG, Treitler PC, Wagner KD, Smith KP, Cooperman N, et al. Emergency department-based peer support for opioid use disorder: emergent functions and forms. J Subst Abuse Treat. 2020;108:82–7.
NYC Department of Health and Mental Hygiene. Information for Peers. Available from: https://www1.nyc.gov/site/doh/health/health-topics/alcohol-and-drug-use-information-for-peers.page.
Samuels EA, Bernstein SL, Marshall BDL, Krieger M, Baird J, Mello MJ. Peer navigation and take-home naloxone for opioid overdose emergency department patients: preliminary patient outcomes. J Subst Abuse Treat. 2018;94:29–34.
Summary of 2019 council resolutions: resolution 50 social work in the Emergency Department American College of Emergency Physicians; 2019. Available from: https://washingtonacep.org/wp-content/uploads/2019-Resolutions-Adopted-by-the-Council-Board.pdf.
Boston Medical Center. The preventive food pantry Boston, MA. Available from: https://www.bmc.org/nourishing-our-community/preventive-food-pantry.
Bridle-Fitzpatrick S. Hospital – food bank partnerships: a recipe for community health: hunger and health; April 25, 2018. Available from: https://hungerandhealth.feedingamerica.org/2018/04/hospital-food-bank-partnerships-recipe-community-health/.
Tsemberis S, Gulcur L, Nakae M. Housing First, consumer choice, and harm reduction for homeless individuals with a dual diagnosis. Am J Public Health. 2004;94(4):651–6.
Urbanoski K, Veldhuizen S, Krausz M, Schutz C, Somers JM, Kirst M, et al. Effects of comorbid substance use disorders on outcomes in a Housing First intervention for homeless people with mental illness. Addiction. 2018;113(1):137–45.
Palepu A, Patterson ML, Moniruzzaman A, Frankish CJ, Somers J. Housing first improves residential stability in homeless adults with concurrent substance dependence and mental disorders. Am J Public Health. 2013;103(Suppl 2):e30–6.
Vuolo L, Oster R, Weber E. Evaluating the promise and potential of the parity act on its tenth anniversary, Health Affairs Blog October 10, 2018. Available from: https://www.healthaffairs.org/do/10.1377/hblog20181009.356245/full/.
Meinhofer A, Witman AE. The role of health insurance on treatment for opioid use disorders: evidence from the Affordable Care Act Medicaid expansion. J Health Econ. 2018;60:177–97.
Lagisetty PA, Ross R, Bohnert A, Clay M, Maust DT. Buprenorphine treatment divide by race/ethnicity and payment. JAMA Psychiatry. 2019;76:979.
Nowotny KM. Race/ethnic disparities in the utilization of treatment for drug dependent inmates in U.S. state correctional facilities. Addict Behav. 2015;40:148–53.
Guerrero EG, Marsh JC, Duan L, Oh C, Perron B, Lee B. Disparities in completion of substance abuse treatment between and within racial and ethnic groups. Health Serv Res. 2013;48(4):1450–67.
Gilbert PA, Pro G, Zemore SE, Mulia N, Brown G. Gender differences in use of alcohol treatment services and reasons for nonuse in a national sample. Alcohol Clin Exp Res. 2019;43(4):722–31.
Cerda M, Gaidus A, Keyes KM, Ponicki W, Martins S, Galea S, et al. Prescription opioid poisoning across urban and rural areas: identifying vulnerable groups and geographic areas. Addiction. 2017;112(1):103–12.
Amiri S, Lutz R, Socias ME, McDonell MG, Roll JM, Amram O. Increased distance was associated with lower daily attendance to an opioid treatment program in Spokane County Washington. J Subst Abuse Treat. 2018;93:26–30.
Guerrero EG, Garner BR, Cook B, Kong Y, Vega WA, Gelberg L. Identifying and reducing disparities in successful addiction treatment completion: testing the role of Medicaid payment acceptance. Subst Abuse Treat Prev Policy. 2017;12(1):27.
Komaromy M, Duhigg D, Metcalf A, Carlson C, Kalishman S, Hayes L, et al. Project ECHO (Extension for Community Healthcare Outcomes): a new model for educating primary care providers about treatment of substance use disorders. Subst Abus. 2016;37(1):20–4.
Tofighi B, Abrantes A, Stein MD. The role of technology-based interventions for substance use disorders in primary care: a review of the literature. Med Clin North Am. 2018;102(4):715–31.
Lord S, Moore SK, Ramsey A, Dinauer S, Johnson K. Implementation of a substance use recovery support mobile phone app in community settings: qualitative study of clinician and staff perspectives of facilitators and barriers. JMIR Ment Health. 2016;3(2):e24.
Anderson M, Kumar M. Digital divide persists even as lower-income Americans make gains in tech adoption: Pew Research Center; 2019. Available from: https://www.pewresearch.org/fact-tank/2019/05/07/digital-divide-persists-even-as-lower-income-americans-make-gains-in-tech-adoption/.
Federal Communications Commission. 2019 Broadband Deployment Report. Federal Communications Commission. https://www.fcc.gov/reports-research/reports/broadbandprogress-reports/2019-broadband-deployment-report. Published May 29, 2019. Accessed August, 2020.
Perrin A. Digital gap between rural and nonrural America persists: Pew Research Center; [updated May 31, 2019]. Available from: https://www.pewresearch.org/fact-tank/2019/05/31/digital-gap-between-rural-and-nonrural-america-persists/.
MassHealth Launches Restructuring To Improve Health Outcomes for 1.2 Million Members [press release]. Boston: Executive Office of Health and Human Services; 2018.
Centers for Medicare and Medicaid Services Innovation Center. Accountable Health Communities Model [updated Nov 13, 2019]. Available from: https://innovation.cms.gov/initiatives/ahcm.
Hunt KA, Weber EJ, Showstack JA, Colby DC, Callaham ML. Characteristics of frequent users of emergency departments. Ann Emerg Med. 2006;48(1):1–8.
LaCalle E, Rabin E. Frequent users of emergency departments: the myths, the data, and the policy implications. Ann Emerg Med. 2010;56(1):42–8.
Curran G, Sullivan G, Williams K, Han X, Allee E, Kotrla K. The association of psychiatric comorbidity and use of the emergency department among persons with substance use disorders: an observational cohort study. BMC Emerg Med J. 2008;8:17.
Moe J, Kirkland SW, Rawe E, Ospina MB, Vandermeer B, Campbell S, et al. Effectiveness of interventions to decrease emergency department visits by adult frequent users: a systematic review. Acad Emerg Med. 2017;24(1):40–52.
Kwan BM, Rockwood A, Bandle B, Fernald D, Hamer MK, Capp R. Community health workers: addressing client objectives among frequent emergency department users. J Public Health Manag Pract. 2018;24(2):146–54.
Bodenmann P, Velonaki VS, Ruggeri O, Hugli O, Burnand B, Wasserfallen JB, et al. Case management for frequent users of the emergency department: study protocol of a randomised controlled trial. BMC Health Serv Res. 2014;14:264.
Sadowski LS, Kee RA, VanderWeele TJ, Buchanan D. Effect of a housing and case management program on emergency department visits and hospitalizations among chronically ill homeless adults: a randomized trial. JAMA. 2009;301(17):1771–8.
Doran KM, Ragins KT, Gross CP, Zerger S. Medical respite programs for homeless patients: a systematic review. J Health Care Poor Underserved. 2013;24(2):499–524.
Warren O, Smith-Bernardin S, Jamieson K, Zaller N, Liferidge A. Identification and practice patterns of sobering centers in the United States. J Health Care Poor Underserved. 2016;27(4):1843–57.
Jarvis SV, Kincaid L, Weltge AF, Lee M, Basinger SF. Public intoxication: sobering centers as an alternative to incarceration, Houston, 2010–2017. Am J Public Health. 2019;109(4):597–9.
American College of Surgeons Committee on Trauma. Resources for the optimal care of the injured patient. Chicago: American College of Surgeons; 2014.
Colorado ACEP. Opioid prescribing & treatment guidelines. Colorado ACEP: Northglenn; 2017.
American College of Emergency Physicians. E-QUAL Network Opioid Initiative 2019. Available from: https://www.acep.org/administration/quality/equal/emergency-quality-network-e-qual/e-qual-opioid-initiative/.
Rhode Island Department of Behavioral Healthcare Developmental Disabilities, and Hospitals, Rhode Island Department of Health. Levels of Care for Rhode Island Emergency Departments and Hospitals for Treating Overdose and Opioid Use Disorder. 2017 March.
Baltimore City Health Department. Levels of care for Baltimore City Hospitals responding to the opioid epidemic guide for Hospitals Baltimore, MD August 2018. Available from: https://health.baltimorecity.gov/sites/default/files/Levels%20of%20Care%20-%20Guide.pdf.
NYC Department of Health and Mental Hygiene. Guidance for the care of patients presenting to New York City Emergency Departments following a non-fatal opioid overdose New York City: NYC Department of Health and Mental Hygiene; May 31, 2019. Available from: https://www1.nyc.gov/assets/doh/downloads/pdf/basas/non-fatal-overdose-providers.pdf.
Massachusetts Health and Hospital Association. Guidelines for medication for addiction treatment for opioid use disorder within the emergency department: Massachusetts Health and Hospital Association; January 2019. Available from: https://www.mhalink.org/MHADocs/MondayReport/2019/18-01-04MATguidelinesNEWFINAL.pdf.
Kilaru AS, Perrone J, Kelley D, Siegel S, Lubitz SF, Mitra N, et al. Participation in a hospital incentive program for follow-up treatment for opioid use disorder. JAMA Netw Open. 2020;3(1):e1918511.
Pennsylvania Department of Human Services. Follow-up treatment after ED visit for opioid use disorder June 6, 2018. Available from: https://www.pamedsoc.org/docs/librariesprovider2/pamed-documents/new-opioid-measures-hqip.pdf?sfvrsn=8524485b_2.
Santiago. Health and Safety Code Section 11757: substance use disorder treatment: peer navigators: California State Legislature; Feb 5 2019. Available from: https://leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=201920200AB389.
Boardman JD, Finch BK, Ellison CG, Williams DR, Jackson JS. Neighborhood disadvantage, stress, and drug use among adults. J Health Soc Behav. 2001;42(2)
Galea S, Nandi A, Vlahov D. The social epidemiology of substance use. Epidemiol Rev. 2004;26:36–52.
Galea S, Rudenstine S, Vlahov D. Drug use, misuse, and the urban environment. Drug Alcohol Rev. 2005;24(2):127–36.
Rothstein R. The Color of Law: a forgotten history of how our government segregated America. Liveright: New York; 2017.
US Census Bureau. 2018 American Community Survey February 13, 2020. Available from: https://www.census.gov/programs-surveys/acs/news/data-releases/2018/release.html#par_textimage_copy.
Schaeffer K. 6 facts about economic inequality in the U.S. Washington, D.C.: Pew Research Center; February 7, 2020. Available from: https://www.pewresearch.org/fact-tank/2020/02/07/6-facts-about-economic-inequality-in-the-u-s/.
Zoorob MJ, Salemi JL. Bowling alone, dying together: the role of social capital in mitigating the drug overdose epidemic in the United States. Drug Alcohol Depend. 2017;173:1–9.
Pear VA, Ponicki WR, Gaidus A, Keyes KM, Martins SS, Fink DS, et al. Urban-rural variation in the socioeconomic determinants of opioid overdose. Drug Alcohol Depend. 2019;195:66–73.
LaVeist TA, Wallace JM. Health risk and inequitable distribution of liquor stores in African American neighborhood. Soc Sci Med. 2000;51(4):613–7.
Bluthenthal RN, Cohen DA, Farley TA, Scribner R, Beighley C, Schonlau M, et al. Alcohol availability and neighborhood characteristics in Los Angeles, California and southern Louisiana. J Urban Health. 2008;85(2):191–205.
Hamad R, Brown DM, Basu S. The association of county-level socioeconomic factors with individual tobacco and alcohol use: a longitudinal study of U.S. adults. BMC Public Health. 2019;19(1):390.
Saloner B, McGinty EE, Beletsky L, Bluthenthal R, Beyrer C, Botticelli M, et al. a public health strategy for the opioid crisis. Public Health Rep. 2018;133(1_suppl):24S–34S.
Ashford RD, Brown AM, Ryding R, Curtis B. Building recovery ready communities: the recovery ready ecosystem model and community framework. Addict Res Theory. 2019;28:1–11.
Cloud W, Granfield R. Conceptualizing recovery capital: expansion of a theoretical construct. Subst Use Misuse. 2008;43(12-13):1971–86.
Matthew DB. Un-burying the lead: public health tools are the key to beating the opioid epidemic. USC-Brookings Schaeffer Initiative for Health Policy; 2018.
Wittman FD, Polcin DL, Sheridan D. The architecture of recovery: two kinds of housing assistance for chronic homeless persons with substance use disorders. Drugs Alcohol Today. 2017;17(3):157–67.
Jason LA, Olson BD, Ferrari JR, Lo Sasso AT. Communal housing settings enhance substance abuse recovery. Am J Public Health. 2006;96(10):1727–9.
Schiff DM, Nielsen T, Hoeppner BB, Terplan M, Hansen H, Bernson D, et al. Assessment of racial and ethnic disparities in the use of medication to treat opioid use disorder among pregnant women in Massachusetts. JAMA Netw Open. 2020;3(5):e205734.
Guerrero EG, Marsh JC, Khachikian T, Amaro H, Vega WA. Disparities in Latino substance use, service use, and treatment: implications for culturally and evidence-based interventions under health care reform. Drug Alcohol Depend. 2013;133(3):805–13.
Valdez LA, Flores M, Ruiz J, Oren E, Carvajal S, Garcia DO. Gender and cultural adaptations for diversity: a systematic review of alcohol and substance abuse interventions for latino males. Subst Use Misuse. 2018;53(10):1608–23.
Perreira KM, Pedroza JM. Policies of exclusion: implications for the health of immigrants and their children. Annu Rev Public Health. 2019;40:147–66.
Alexander M. The New Jim Crow: mass incarceration in the age of colorblindness. New York: Jackson, Tenn New Press; 2010.
Koester S, Mueller SR, Raville L, Langegger S, Binswanger IA. Why are some people who have received overdose education and naloxone reticent to call Emergency Medical Services in the event of overdose? Int J Drug Policy. 2017;48:115–24.
Gonsalves GS, Crawford FW. Dynamics of the HIV outbreak and response in Scott County, IN, USA, 2011–15: a modelling study. The Lancet HIV. 2018;5(10):e569–e77.
Flath N, Tobin K, King K, Lee A, Latkin C. enduring consequences from the war on drugs: how policing practices impact HIV risk among people who inject drugs in Baltimore city. Subst Use Misuse. 2017;52(8):1003–10.
Goedel WC, King MRF, Lurie MN, Galea S, Townsend JP, Galvani AP, et al. Implementation of syringe services programs to prevent rapid human immunodeficiency virus transmission in rural counties in the United States: a modeling study. Clin Infect Dis. 2019;
Davis CS, Carr DH, Samuels EA. Paraphernalia laws, criminalizing possession and distribution of items used to consume illicit drugs, and injection-related harm. Am J Public Health. 2019;109(11):1564–7.
Fazel S, Yoon IA, Hayes AJ. Substance use disorders in prisoners: an updated systematic review and meta-regression analysis in recently incarcerated men and women. Addiction. 2017;112(10):1725–39.
The Drug Policy Alliance. The drug war, mass incarceration and race. The Drug Policy Alliance: New York; 2018.
Pew Charitable Trusts. More imprisonment does not reduce state drug problems: data show no relationship between prison terms and drug misuse. Washington, D.C.: Pew Charitable Trusts; 2018.
Wolff N, Huening J, Shi J, Frueh BC. Trauma exposure and posttraumatic stress disorder among incarcerated men. J Urban Health. 2014;91(4):707–19.
Hinton E. From the war on poverty to the war on crime: the making of mass incarceration in America. Cambridge, MA: Harvard University Press; 2016.
Rosenberg A, Groves AK, Blankenship KM. Comparing black and white drug offenders: implications for racial disparities in criminal justice and reentry policy and programming. J Drug Issues. 2017;47(1):132–42.
Substance Abuse and Mental Health Services Administration. Medication-Assisted Treatment (MAT) in the criminal justice system: brief guidance to the states: Substance Abuse and Mental Health Services Administration; March 2019. Available from: https://store.samhsa.gov/system/files/pep19-matbriefcjs.pdf.
Green TC, Clarke J, Brinkley-Rubinstein L, Marshall BDL, Alexander-Scott N, Boss R, et al. Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System. JAMA Psychiatry. 2018;75(4):405–7.
Marsden J, Stillwell G, Jones H, Cooper A, Eastwood B, Farrell M, et al. Does Exposure to Opioid Substitution Treatment in Prison Reduce the Risk of Death After Release? A National Prospective Observational Study in England. Addiction. 2017;112(8):1408–18.
Degenhardt L, Larney S, Kimber J, Gisev N, Farrell M, Dobbins T, et al. The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study. Addiction. 2014;109(8):1306–17.
Wildeman C, Wang EA. Mass incarceration, public health, and widening inequality in the USA. The Lancet. 2017;389(10077):1464–74.
Ban the Box Campaign. Available from: https://bantheboxcampaign.org.
Matthew DB. Un-burying the lead: public health tools are the key to beating the opioid epidemic. USC-Brookings Schaeffer Initiative for Health Policy; 2018.
Ordinance 125393: fair chance housing ordinance August 23, 2017. Available from: http://seattle.legistar.com/View.ashx?M=F&ID=5387389&GUID=6AA5DDAE-8BAE-4444-8C17-62C2B3533CA3.
Peters RH, Young MS, Rojas EC, Gorey CM. Evidence-based treatment and supervision practices for co-occurring mental and substance use disorders in the criminal justice system. Am J Drug Alcohol Abuse. 2017;43(4):475–88.
Tsai J, Flatley B, Kasprow WJ, Clark S, Finlay A. Diversion of veterans with criminal justice involvement to treatment courts: participant characteristics and outcomes. Psychiatr Serv. 2017;68(4):375–83.
The Center for Health and Justice at TASC. No entry: a national survey of criminal justice diversion programs and initiatives. Chicago: The Center for Health and Justice at TASC; 2013.
Nicosia N, Macdonald JM, Arkes J. Disparities in criminal court referrals to drug treatment and prison for minority men. Am J Public Health. 2013;103(6):e77–84.
Goncalves R, Lourenco A, Silva SN. A social cost perspective in the wake of the Portuguese strategy for the fight against drugs. Int J Drug Policy. 2015;26(2):199–209.
Ferreira S. Portugal’s radical drugs policy is working. Why hasn’t the world copied it? The Guardian. 2017 Dec 5.
Bajekal N. Want to win the war on drugs? Portugal might have the answer. Time. 2018 Aug 1.
Sharbaugh MS, Althouse AD, Thoma FW, Lee JS, Figueredo VM, Mulukutla SR. Impact of cigarette taxes on smoking prevalence from 2001-2015: a report using the Behavioral and Risk Factor Surveillance Survey (BRFSS). PLoS One. 2018;13(9):e0204416.
Frazer K, Callinan JE, McHugh J, van Baarsel S, Clarke A, Doherty K, et al. Legislative smoking bans for reducing harms from secondhand smoke exposure, smoking prevalence and tobacco consumption. Cochrane Database Syst Rev. 2016;(2):CD005992.
National Conference of State Legislatures. State Medical Marijuana Laws June 5, 2019. Available from: http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx.
National Conference of State Legislatures. Marijuana Overview May 28, 2019. Available from: http://www.ncsl.org/research/civil-and-criminal-justice/marijuana-overview.aspx.
Kuehn B. Declining opioid prescriptions. JAMA. 2019;321(8):736.
Dowell D, Haegerich T, Chou R. CDC guideline for prescribing opioids for chronic pain – United States, 2016. MMWR Recomm Rep. 2016;65(1):1–49.
Herring AA, Perrone J, Nelson LS. Managing opioid withdrawal in the emergency department with buprenorphine. Ann Emerg Med. 2019;73(5):481–7.
Herring A, Snyder H, Moulin A, Luftig J, Sampson A, Trozky R, et al. Buprenorphine Guide: ED-BRIDGE; 2018. Available from: https://ed-bridge.org/guide.
Sallis JF, Owen N, Fisher EB. Ecological models of health behavior. In: Glanz KRB, Viswanath K, editors. Health behavior and health education. 4th ed. San Francisco: Wiley; 2008. p. 465–85.
Editors and Affiliations
Rights and permissions
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Samuels, E.A., Xuan, Z., Bernstein, E. (2021). Substance Use: A Social Emergency Medicine Perspective. In: Alter, H.J., Dalawari, P., Doran, K.M., Raven, M.C. (eds) Social Emergency Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-65672-0_10
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-65671-3
Online ISBN: 978-3-030-65672-0
eBook Packages: MedicineMedicine (R0)